Iran-Developed Nanoliposome Technology Paves Way for Higher Absorption of Supplements
8:05 - December 13, 2023

Iran-Developed Nanoliposome Technology Paves Way for Higher Absorption of Supplements

TEHRAN (ANA)- Specialists at a knowledge-based company in Iran improved the absorption and effectiveness of supplements by using nanoliposome technology.
News ID : 4462

“Among the knowledge-based products of our company, we can mention pharmaceutical products and liposomal nutritional supplements, including homosomal iron drops, liposomal vitamin D, and immunosome,” said Farnaz Mirzazadeh, the managing director of the knowledge-based company.

“This supplement consists of liposomes with two phospholipid layers in a matrix of sucrose ester, which, in addition to more stabilization, provides more complete absorption of salts and vitamins through different mechanisms. Also, this product has minimized the side effects caused by calcium salt and its absorption interactions with other substances,” she said.

Mirzazadeh also referred to the production of homosome plus syrup, saying, “This food supplement contains iron, folic acid and vitamin B12 in the form of sucroliposomal particles. This product is used to treat iron deficiency anemia in children and adults.”

Noting that the product does not change the color of teeth, she said, “Its formulation contains particles that have nanoliposomes of sunflower lecithin with dimensions less than 100 nm, which are stabilized by a matrix of sucrose ester and starch, and it increases the possibility of more complete absorption, more effectiveness and less side effects by iron, vitamins B12 and folic acid.”

Earlier, experts at an Iranian nanotechnology company had also used the nanoliposome technology to produce a new topical gel which can treat cutaneous leishmaniasis (CL) disease.

‘Exir Nano Sina’ firm has made the product which is a topical gel based on the nanoliposome technology and its main component is a polyene anti-parasitic and anti-fungal drug.

The gel can be typically used for treating the cutaneous leishmaniasis and has trivial side effects and lower cost.

The encapsulation of the main drug by the nanoliposomal structures has led to promoting the drug penetration into the affected tissue and reducing the detrimental side effects of the drug on the body.

The cream can be used for the treatment of cutaneous leishmaniasis and topical fungal diseases.

4155/v

 

 

Send comment